1 Result(s)

Article

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

Immunochemotherapy is the first-line standard for extensive-stage small-cell lung cancer (ES-SCLC). Combining the regimen with anti-angiogenesis may improve efficacy. ETER701 was a multicenter, double-blind, r...

Ying Cheng, Jianhua Chen, Wei Zhang, Chao **e, Qun Hu, Ningning Zhou… in Nature Medicine (2024)